Taking Action from RWE Analytics: Use of Health Insights Dataset Reveal Underdiagnosis and Care Gaps in NASH and NAFLD

Nonalcoholic fatty liver disease (NAFLD), including the more aggressive NASH (nonalcoholic steatohepatitis), has become a major public health concern, affecting about one in four Americans (Younossie 2018). Its increasing prevalence parallels rising rates of obesity and type 2 diabetes. Continue Reading

Using AI, NLP and Data Visualization with RWE to Generate Insights into Care Gaps: Retrospective Cohort Analysis of Fracture Risk in Patients with Osteopenia and Osteoporosis

This blog reports practical uses of RWD sourced from the largest, cloud-based electronic health record (EHR) platform in the United States, offered by Veradigm® as part of its Health Insights database. Continue Reading

Tackling Rare Diseases with an Arsenal of Real-World Data

Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and other high-value subphenotypes. Continue Reading

How Artificial Intelligence and Real World Data Can Improve the Management of Type 2 Diabetes: A Case Study

See how Veradigm, a business unit of Allscripts focused on generating data-driven healthcare insights using EHR data applied artificial intelligence to EHRs to improve therapeutic management of patients with concordant comorbidities who are living with type 2 diabetes. Continue Reading

Changing the Clinical Trial Paradigm for Rare and Orphan (R&O) Diseases using Real-World Evidence

Interview with Flora Sandra Siami, MPH. Vice President of Clinical Research, Regulatory Affairs, and Quality Assurance at HealthCore-NERI. Dr. Patti Peeples, CEO of HealthEconomics.Com, sat down with Flora Sandra Siami, MPH, Vice President of Clinical Research, Regulatory Affairs, and Quality… Continue Reading